Publications by authors named "P E Rouby"

Introduction: Training to disclose bad news in a pluridisciplinary format facilitates communication and improves learning. There are many different debriefing methods described in the literature. The aim of this study was to compare and evaluate the value of final debriefing and microdebriefing with interruptions of the scenario in a simulation program about communication in unexpected complications from perioperative care.

View Article and Find Full Text PDF

The therapeutic arsenal for advanced ALK positive non-small cell lung cancer has been enriched by specific treatments targeting this molecular abnormality, with five molecules available, including lorlatinib, approved since July 2020. This treatment can have side effects common to other tyrosine kinase inhibitors, as well as other less common disorders affecting the central nervous system such as impaired cognitive function, speech or mood. The prevalence of neuro-psychiatric effects under treatment with lorlatinib reported in studies is nearly 40 % with a mild to moderate intensity in most cases.

View Article and Find Full Text PDF

Introduction: Disclosure of damage related to care is a difficult area of communication due to the physician's feeling of guilt or the fear of liability. The aim of this study was to develop, and to evaluate the impact of an inter-disciplinary simulation program on communication of damage related to care.

Methods: Residents in gynecology/obstetrics and anesthesiology participated in role-playing scenarios of communication of damage related to care.

View Article and Find Full Text PDF
Article Synopsis
  • * While long-term treatment-free remissions have been noted in other cancers, there is still no clear consensus on the optimal duration of ICI treatment, highlighting the need for more randomized controlled trials.
  • * The text suggests that, particularly for melanoma patients, it is generally considered safe to stop ICI therapy after confirming a CR and having at least 6 months of treatment, and it discusses the implications of this treatment cessation for patient management.
View Article and Find Full Text PDF